COMMUNIQUÉS West-GlobeNewswire

Crown Bioscience Launches CrownSyn™, an Innovative Bioinformatics Solution that Simplifies the Characterization of Two-Drug Combination Studies

09/01/2018 - 14:00

SAN DIEGO, Jan. 09, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience , a wholly-owned subsidiary of Crown Bioscience International (TWSE:6554) and a global drug discovery and development services company providing [...]

Johnson & Johnson Veteran Chuck Austin To Scale Up BioSig Operations

09/01/2018 - 14:00

Santa Monica, CA, Jan. 09, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet [...]

GBT Receives FDA Breakthrough Therapy Designation for Voxelotor for Treatment of Sickle Cell Disease (SCD)

09/01/2018 - 14:00

SOUTH SAN FRANCISCO, Calif., Jan. 09, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT ) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy [...]

Pain Therapeutics Reports Positive Top-line Results from Nasal Abuse Potential Study with REMOXY™

09/01/2018 - 14:00

- Study Meets Primary Endpoint (p<0.01) - - REMOXY NDA Remains On-Track for Resubmission in Q1 2018 - AUSTIN, Texas, Jan. 09, 2018 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq: PTIE ) today announced positive [...]

Inovio Pharmaceuticals and the Parker Institute for Cancer Immunotherapy Establish Clinical Development Collaboration To Evaluate Novel Cancer Immunotherapy Combinations

09/01/2018 - 14:00

Advances development of Inovio’s ASPIRE ™ (Antigen SPecific Immune REsponses) immunotherapy platform as a foundation for novel combination regimen approaches Engages the Parker Institute’s extensive immunotherapy [...]

Cannabis Wheaton Income Corp. Announces Filing of Final Base Shelf Prospectus

09/01/2018 - 14:00

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION TO UNITED STATES VANCOUVER, British Columbia, Jan. 09, 2018 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (d/b/a Wheaton Income) (TSX-V: [...]

Incysus Submits Second Investigational New Drug Application for Gamma-Delta T Cell Immunotherapy Candidate

09/01/2018 - 13:30

NEW YORK, Jan. 09, 2018 (GLOBE NEWSWIRE) -- Incysus, Ltd., a biopharmaceutical company focused on delivering an innovative gamma-delta (γδ) T cell immunotherapy for the treatment of cancers, today announced the [...]

Otonomy Provides Corporate and Product Pipeline Update

09/01/2018 - 13:30

SAN DIEGO, Jan. 09, 2018 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC ), a biopharmaceutical company dedicated to the development of innovative therapeutics for diseases and disorders of the ear, today provided an [...]

REPEAT: Cannabis Wheaton Income Corp. Announces Strategic Investment and Alliance With Inner Spirit Holdings Ltd.

09/01/2018 - 13:30

VANCOUVER, British Columbia, Jan. 09, 2018 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (d/b/a Wheaton Income) (TSX-V: CBW ) (" Wheaton Income " or the " Company ") is pleased to announce that it has entered into [...]

GenMark Diagnostics Provides Preliminary Operational and Financial Results for 2017

09/01/2018 - 13:05

CARLSBAD, Calif., Jan. 09, 2018 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK ), a leading provider of automated, multiplex molecular diagnostic testing systems, today provided preliminary operational and [...]

Sonoma Pharmaceuticals Receives Three New United Arab Emirates Regulatory Approvals: Acuicyn® for Management of Blepharitis, Microsafe® Oral Care for Mucositis and Sinudox® for Chronic Sinusitis

09/01/2018 - 13:05

PETALUMA, Calif., Jan. 09, 2018 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA, warrants SNOAW), a specialty pharmaceutical company that develops and markets unique and effective solutions for the [...]

Summit Therapeutics to Present at the Biotech Showcase

09/01/2018 - 13:01

Summit Therapeutics plc ("Summit", or the "Company") SUMMIT THERAPEUTICS TO PRESENT AT THE BIOTECH SHOWCASE Oxford, UK, 9 January 2018 - Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM), the drug discovery and [...]

Medtronic Enrolls First Patient In Pain Study to Assess Optimized Spinal Cord Stimulation Programming

09/01/2018 - 13:01

As More Physicians Seek Non-Opioid Treatment Options, the Vectors Study Will Further Advance Understanding of New Approaches to Optimal Spinal Cord Stimulation Treatment DUBLIN - January 9, 2018 - Medtronic plc (NYSE: [...]

Tonix Pharmaceuticals Appoints Jessica Morris as Chief Operating Officer

09/01/2018 - 13:00

NEW YORK, Jan. 09, 2018 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP ) (Tonix), a company developing innovative pharmaceutical and biological products to address major public health challenges, [...]

Cyclacel Reviews 2017 Achievements and Announces Key Business Objectives for 2018

09/01/2018 - 13:00

BERKELEY HEIGHTS, N.J., Jan. 09, 2018 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq: CYCC ) (Nasdaq: CYCCP ) (Cyclacel or the Company) reviewed its 2017 achievements and provided an outline of the Company's [...]

Summit Therapeutics to Present at the Biotech Showcase

09/01/2018 - 13:00

OXFORD, United Kingdom, Jan. 09, 2018 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ: SMMT ) (AIM:SUMM), the drug discovery and development company advancing therapies for rare diseases and infectious diseases, [...]

Ziopharm Oncology Provides Update on Standout Technologies during the 36th Annual J.P. Morgan Healthcare Conference

09/01/2018 - 13:00

- Controlled IL-12 advancing as drug platform as monotherapy and in combination with OPDIVO ® (nivolumab) - - Non-viral T-cell platform shows potential for efficacy, scalability and cost reduction for multiple oncology [...]

IRIDEX Announces Infringement Lawsuit Against Quantel

09/01/2018 - 13:00

MOUNTAIN VIEW, Calif., Jan. 09, 2018 (GLOBE NEWSWIRE) -- IRIDEX Corporation (NASDAQ: IRIX ) announced today that it has filed a lawsuit against Quantel Medical, S.A., Quantel USA, Inc., and Quantel, S.A. in the U.S. [...]

Axsome Therapeutics Announces AXS-02 Independent Data Monitoring Committee Recommends Continuation of COAST-1 Trial and Discontinuation of CREATE-1 Trial

09/01/2018 - 13:00

COAST-1 is a Phase 3 trial of AXS-02 in knee osteoarthritis associated with bone marrow lesions CREATE-1 is a Phase 3 trial of AXS-02 in complex regional pain syndrome Significant reduction in bone resorption confirms [...]